The clinical importance of the neonatal Fc receptor in RPE.

Recruiting

• Conditions: age related macular degeneration; 10047060

• Registration Number: NL-OMON32041
• Lead Sponsor: Oogziekenhuis Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

- Age >= 18 years
- Informed consent
- Age related macular degeneration (ARMD group) or no ARMD (control group)

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Confirmation of the role of FcRn in metabolism and transport of vitreous IgG<br /><br>and monoclonals (Avastin, Lucentis), frequency of FcRn mutations and<br /><br>polymorphisms.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>